SNN vs. GILD

Last updated Apr 2, 2026

Compare and contrast key facts about Smith & Nephew plc (SNN) and Gilead Sciences, Inc. (GILD).

Performance

SNN vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Smith & Nephew plc (SNN) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

SNN vs. GILD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SNN Smith & Nephew plc	-0.71%	36.82%	-7.34%	4.44%	-20.20%	-16.21%	-10.40%	30.84%	8.90%	18.57%
GILD Gilead Sciences, Inc.	14.96%	36.59%	18.68%	-1.99%	23.63%	29.95%	-6.70%	7.88%	-9.92%	2.96%

Fundamentals

Market Cap SNN : $14.01B GILD : $175.80B
EPS SNN : $2.37 GILD : $6.79
PE Ratio SNN : 13.54 GILD : 20.67
PEG Ratio SNN : 0.47 GILD : 0.05
PS Ratio SNN : 1.17 GILD : 5.98
PB Ratio SNN : 2.65 GILD : 7.77
Total Revenue (TTM) SNN : $11.99B GILD : $29.44B
Gross Profit (TTM) SNN : $8.25B GILD : $23.79B
EBITDA (TTM) SNN : $2.82B GILD : $12.90B

Returns By Period

In the year-to-date period, SNN achieves a -0.71% return, which is significantly lower than GILD's 14.96% return. Over the past 10 years, SNN has underperformed GILD with an annualized return of 1.95%, while GILD has yielded a comparatively higher 7.81% annualized return.

SNN

• 1D: 0.98%
• 1M: -8.90%
• YTD: -0.71%
• 6M: -10.74%
• 1Y: 16.52%
• 3Y*: 7.59%
• 5Y*: -0.60%
• 10Y*: 1.95%

GILD

• 1D: 0.67%
• 1M: -5.95%
• YTD: 14.96%
• 6M: 27.78%
• 1Y: 29.43%
• 3Y*: 23.25%
• 5Y*: 20.53%
• 10Y*: 7.81%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SNN vs. GILD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNN

SNN Risk / Return Rank: 58
SNN Sharpe Ratio Rank: 61
SNN Sortino Ratio Rank: 54
SNN Omega Ratio Rank: 56
SNN Calmar Ratio Rank: 61
SNN Martin Ratio Rank: 58

GILD

GILD Risk / Return Rank: 73
GILD Sharpe Ratio Rank: 74
GILD Sortino Ratio Rank: 70
GILD Omega Ratio Rank: 64
GILD Calmar Ratio Rank: 77
GILD Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SNN vs. GILD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Smith & Nephew plc (SNN) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SNN	GILD	Difference
Sharpe ratio Return per unit of total volatility	0.56	1.02	-0.46
Sortino ratio Return per unit of downside risk	1.00	1.63	-0.63
Omega ratio Gain probability vs. loss probability	1.14	1.19	-0.05
Calmar ratio Return relative to maximum drawdown	0.93	2.07	-1.14
Martin ratio Return relative to average drawdown	1.79	5.62	-3.83
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SNN vs. GILD - Sharpe Ratio Comparison

The current SNN Sharpe Ratio is 0.56, which is lower than the GILD Sharpe Ratio of 1.02. The chart below compares the historical Sharpe Ratios of SNN and GILD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SNN	GILD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.56	1.02	-0.46
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.02	0.86	-0.89
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.07	0.31	-0.23
Sharpe Ratio (All Time) Calculated using the full available price history	0.29	0.39	-0.10

Correlation

The correlation between SNN and GILD is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SNN vs. GILD - Dividend Comparison

SNN's dividend yield for the trailing twelve months is around 2.44%, more than GILD's 2.27% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SNN Smith & Nephew plc	2.44%	2.32%	3.05%	2.75%	2.79%	2.17%	1.78%	1.51%	1.96%	1.76%	2.08%	1.68%
GILD Gilead Sciences, Inc.	2.27%	2.57%	3.33%	3.70%	3.40%	3.91%	4.67%	3.88%	3.65%	2.90%	2.57%	1.27%

Drawdowns

SNN vs. GILD - Drawdown Comparison

The maximum SNN drawdown since its inception was -55.20%, smaller than the maximum GILD drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for SNN and GILD.

Drawdown Indicators

	SNN	GILD	Difference
Max Drawdown Largest peak-to-trough decline	-55.20%	-70.83%	+15.63%
Max Drawdown (1Y) Largest decline over 1 year	-16.89%	-13.77%	-3.12%
Max Drawdown (5Y) Largest decline over 5 years	-49.18%	-26.59%	-22.59%
Max Drawdown (10Y) Largest decline over 10 years	-55.06%	-36.01%	-19.05%
Current Drawdown Current decline from peak	-26.69%	-9.44%	-17.25%
Average Drawdown Average peak-to-trough decline	-17.57%	-22.20%	+4.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.80%	5.08%	+3.72%

Volatility

SNN vs. GILD - Volatility Comparison

Smith & Nephew plc (SNN) and Gilead Sciences, Inc. (GILD) have volatilities of 6.19% and 6.36%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SNN	GILD	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.19%	6.36%	-0.17%
Volatility (6M) Calculated over the trailing 6-month period	19.70%	18.91%	+0.79%
Volatility (1Y) Calculated over the trailing 1-year period	29.60%	29.01%	+0.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.88%	23.90%	+2.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.74%	25.63%	+1.11%

Financials

SNN vs. GILD - Profitability Comparison

The chart below illustrates the profitability comparison between Smith & Nephew plc and Gilead Sciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SNN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Smith & Nephew plc reported a gross profit of 2.09B and revenue of 3.19B. Therefore, the gross margin over that period was 65.6%.

GILD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported a gross profit of 6.88B and revenue of 7.93B. Therefore, the gross margin over that period was 86.8%.

SNN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Smith & Nephew plc reported an operating income of 570.45M and revenue of 3.19B, resulting in an operating margin of 17.9%.

GILD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported an operating income of 2.96B and revenue of 7.93B, resulting in an operating margin of 37.4%.

SNN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Smith & Nephew plc reported a net income of 330.82M and revenue of 3.19B, resulting in a net margin of 10.4%.

GILD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported a net income of 2.18B and revenue of 7.93B, resulting in a net margin of 27.6%.